AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test
Welcome to DNA Labs UAE, where we offer the AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test. This test is designed to diagnose and analyze the AVPR2 gene associated with nephrogenic syndrome of inappropriate antidiuresis (NSIAD), a rare genetic disorder.
Test Details
The AVPR2 gene is responsible for NSIAD, a condition characterized by excessive water reabsorption in the kidneys. This leads to an inability to properly regulate urine production, resulting in concentrated urine and potential complications such as low blood sodium levels (hyponatremia).
Our AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test utilizes Next-Generation Sequencing (NGS) technology to analyze the DNA sequence of genes, including the AVPR2 gene. This allows us to identify any mutations or abnormalities associated with NSIAD. By detecting specific mutations in the AVPR2 gene, we can confirm a diagnosis of NSIAD.
By identifying the genetic cause of NSIAD, our NGS genetic testing provides important information for patients and their families. This includes an accurate diagnosis, prognosis, and potential treatment options. Additionally, it can assist with genetic counseling and family planning decisions.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology, Nephrology, Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by NSIAD and the AVPR2 gene.
For more information or to schedule an appointment, please contact our genetics department.
Test Name | AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AVPR2 Gene Nephrogenic syndrome of inapproriate antidiuresis NGS Genetic DNA Test gene AVPR2 |
Test Details |
The AVPR2 gene is associated with nephrogenic syndrome of inappropriate antidiuresis (NSIAD), which is a rare genetic disorder characterized by excessive water reabsorption in the kidneys. This condition leads to an inability to properly regulate urine production, resulting in excessive urine concentration and potential complications such as hyponatremia (low blood sodium levels). NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to analyze the DNA sequence of genes, including the AVPR2 gene, to identify any mutations or abnormalities. This test can help confirm a diagnosis of NSIAD by detecting specific mutations in the AVPR2 gene that are known to be associated with the condition. By identifying the genetic cause of NSIAD, NGS genetic testing can provide important information for patients and their families, including accurate diagnosis, prognosis, and potential treatment options. It can also help with genetic counseling and family planning decisions. |